Diabetes

Supplier News — Fera Pharmaceuticals has recently launched two new topical ointments. The New York-based company has developed Ilotycin (erythromycin) and Garamycin (gentamicin) ophthalmic ointments, both for the treatment of bacterial infections of the eye. “Our goal is simple: to keep more quality healthcare choices alive for the people who need them,” company co-founder Frank DellaFera said.


SAN DIEGO — As retail distribution for GreatCall's Jitterbug J cell phones expands, the company has placed a stronger emphasis on its health-and-wellness apps for the Jitterbug handsets.

Drug Store News recently sat down with Scott Verner, president of Nipro Diagnostics, to discuss some of the synergies created by the acquisition of Home Diagnostics by Japan’s Nipro in March. 


Drug Store News: How is the new company better positioned in the U.S. market? What are the synergies?


PASADENA, Calif. — A new study published in the Journal of Pediatrics found that the use of tobacco products among young diabetics is on the rise, and many haven't been counseled by their healthcare providers to not smoke or stop smoking.

CONSHOHOCKEN, Pa. — The need to communicate crucial health conditions to 
medical personnel responding to an accident or unresponsive patient is becoming more important, especially considering the increase in such chronic conditions as diabetes or allergies. And that need is expected to become a crucial driver behind the sale of fashionable medical alert bracelets.

ATLANTA — The Centers for Disease Control and Prevention has set aside the week of Dec. 5 to observe this season's National Influenza Vaccination Week. The week-long emphasis on flu vaccination was established to highlight the importance of continuing influenza vaccination, as well as foster greater use of flu vaccine after the holiday season into January and beyond.

BETHESDA, Md. — Good results from an investigational diabetes drug made by Spherix may result from higher body mass indexes among U.S. patients, according to results of a late-stage clinical trial announced Thursday.

Spherix said results of the phase-3 trial conducted among American and Indian patients indicated that D-tagatose may be more effective in lowering HbA1c levels due to Americans having higher BMIs on average than Indians.

BOSTON — According to a report in the December 2010 issue of the Harvard Health Letter, Americans are maintaining intimacy through their 60s, 70s and even 80s.

The article summed up findings from two surveys investigating intimacy health in older Americans. Indiana University researchers reported earlier this year that 20% to 30% of long-lived Americans are active into their 80s. And a University of Chicago survey originally published in 2007 found that half of Americans continue to engage well into their 70s.